BMO Capital Initiates Coverage On Enovis with Outperform Rating, Announces Price Target of $29

Enovis Corporation

Enovis Corporation

ENOV

0.00

BMO Capital analyst Vik Chopra initiates coverage on Enovis (NYSE: ENOV) with a Outperform rating and announces Price Target of $29.